Protective Role of Tangshen Formula on the Progression of Renal Damage in db/db Mice by TRPC6/Talin1 Pathway in Podocytes
- PMID: 33015191
- PMCID: PMC7519445
- DOI: 10.1155/2020/3634974
Protective Role of Tangshen Formula on the Progression of Renal Damage in db/db Mice by TRPC6/Talin1 Pathway in Podocytes
Abstract
Tangshen Formula (TSF) is a Chinese Medicine formula that has been reported to alleviate proteinuria and protect renal function in humans and animals with diabetic kidney disease (DKD). However, little is known about its mechanism in improving proteinuria. The dysregulation of podocyte cell-matrix adhesion has been demonstrated to play an important role in the pathogenesis and progression of proteinuric kidney diseases including DKD. In the present study, the underlying protective mechanism of TSF on podocytes was investigated using the murine model of type 2 DKD db/db mice in vivo and advanced glycation end products (AGEs)-stimulated primary mice podocytes in vitro. Results revealed that TSF treatment could significantly mitigate reduction of podocyte numbers and foot process effacement, reduce proteinuria, and protect renal function in db/db mice. There was a significant increase in expression of transient receptor potential canonical channel 6 (TRPC6) and a decrease in expression of talin1 in podocytes of db/db mice. The results of AGEs-stimulated primary mice podocytes showed increased cell migration and actin-cytoskeleton rearrangement. Moreover, primary mice podocytes stimulated by AGEs displayed an increase in TRPC6-dependent Ca2+ influx, a loss of talin1, and translocation of nuclear factor of activated T cell (NFATC) 2. These dysregulations in mice primary podocytes stimulated by AGEs could be significantly attenuated after TSF treatment. 1-Oleoyl-2-acetyl-sn-glycerol (OAG), a TRPC6 agonist, blocked the protective role of TSF on podocyte cell-matrix adherence. In conclusion, TSF could protect podocytes from injury and reduce proteinuria in DKD, which may be mediated by the regulation of the TRPC6/Talin1 pathway in podocytes.
Copyright © 2020 Qian Wang et al.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures








Similar articles
-
Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy.J Ethnopharmacol. 2024 Apr 24;324:117721. doi: 10.1016/j.jep.2024.117721. Epub 2024 Jan 8. J Ethnopharmacol. 2024. PMID: 38199335
-
Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.Drug Des Devel Ther. 2020 Jan 28;14:361-370. doi: 10.2147/DDDT.S234262. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32095070 Free PMC article.
-
Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.Mol Med Rep. 2019 Mar;19(3):2421-2430. doi: 10.3892/mmr.2019.9871. Epub 2019 Jan 17. Mol Med Rep. 2019. PMID: 30664212
-
Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement.J Diabetes Res. 2020 Jan 3;2020:6897390. doi: 10.1155/2020/6897390. eCollection 2020. J Diabetes Res. 2020. PMID: 31998809 Free PMC article. Review.
-
Role of TRPC6 in Progression of Diabetic Kidney Disease.Curr Hypertens Rep. 2019 May 21;21(7):48. doi: 10.1007/s11906-019-0960-9. Curr Hypertens Rep. 2019. PMID: 31115705 Free PMC article. Review.
Cited by
-
An update on the secretory functions of brown, white, and beige adipose tissue: Towards therapeutic applications.Rev Endocr Metab Disord. 2024 Apr;25(2):279-308. doi: 10.1007/s11154-023-09850-0. Epub 2023 Dec 5. Rev Endocr Metab Disord. 2024. PMID: 38051471 Free PMC article. Review.
-
Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria.Cells. 2022 Aug 11;11(16):2499. doi: 10.3390/cells11162499. Cells. 2022. PMID: 36010576 Free PMC article. Review.
-
Fufang shenhua tablet, astragali radix and its active component astragaloside IV: Research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney.Front Pharmacol. 2023 Apr 5;14:1131635. doi: 10.3389/fphar.2023.1131635. eCollection 2023. Front Pharmacol. 2023. PMID: 37089929 Free PMC article. Review.
-
Ion channels and channelopathies in glomeruli.Physiol Rev. 2023 Jan 1;103(1):787-854. doi: 10.1152/physrev.00013.2022. Epub 2022 Aug 25. Physiol Rev. 2023. PMID: 36007181 Free PMC article. Review.
-
Rapid identification of chemical components in Xuelian granule by UHPLC-Q-orbitrap-HRMS based on enzyme activity in vitro.BMC Complement Med Ther. 2023 Jul 5;23(1):222. doi: 10.1186/s12906-023-04025-5. BMC Complement Med Ther. 2023. PMID: 37407958 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous